期刊文献+

采用蛋白质组学技术鉴定肝癌细胞株HepG2的G_1期细胞的hnRNPA2/B1蛋白

Identification of hnRNPA2/B1 Protein in G_1 Phase from HepG2 Using Proteomics Technique
原文传递
导出
摘要 [目的]采用蛋白质组学技术鉴定肝癌细胞株HepG2的G1期细胞内的不均一性核糖核蛋白A2/B1(hnRNPA2/B1)蛋白。[方法]提取肝癌细胞株HepG2的G1期细胞的蛋白质,采用双向电泳方法分离蛋白质,应用图像扫描仪及质谱(MALDI-TOF-MS)分析鉴定HepG2的G1期细胞表达的蛋白质。[结果]采用双向电泳技术分离,并用质谱成功鉴定出HepG2的G1期细胞的hnRNPA2/B1。[结论]肝癌细胞株HepG2的G1期细胞内的hnRN-PA2/B1蛋白的成功鉴定,为探讨其在肝癌细胞生长和增殖中的作用奠定了基础,并为临床上肿瘤的治疗提供参考依据。 [Purpose] To identify hnRNPA2/B1 protein in G1 phase from HepG2 by the proteomics methods. [Methods] G1 phase Proteins of HepG2 cells were extracted and separated by two-dimensional electrophoresis,and the hnRNPA2/B1 proteins were identified by image scanner and MALDI-TOF-MS. [Results] HnRNPA2/B1 protein in G1 phase from HepG2 was successfully separated and identified. [Conclusion] The hnRNPA2/B1 protein in G1 phase from HepG2 is identified successfully. It can provide the basis of the treatment for tumor.
出处 《肿瘤学杂志》 CAS 2013年第7期505-508,共4页 Journal of Chinese Oncology
关键词 肝肿瘤 HEPG2 蛋白质组学 hnRNPA2 B1蛋白 liver neoplasms HepG2 proteomics hnRNPA2/B1 protein
  • 相关文献

参考文献2

二级参考文献15

  • 1曹箭,潘秦镜,李中林,刘树范.纤维支气管镜ThinPrep技术刷片细胞病理检查的诊断价值[J].中华肿瘤杂志,2006,28(7):536-538. 被引量:24
  • 2Tanner NT, Silvestri GA. An up to date look at lung cancer screening. Cell Adh Migr, 2010, 4:96-99.
  • 3Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer, 2006, 118:257-262.
  • 4Singhal S, Vachani A, Antin-Ozerkis D, et al. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res, 2005, 11:3974- 3986.
  • 5Sueoka E, Sueoka N, Goto Y, et al. Heterogeneous nuclear ribonucleo- protein B1 as early cancer biomarker for occult cancer of huaman lungs and bronchial dysplasia. Cancer Res, 2001, 61: 1896- 1902.
  • 6Garg S, Handa U, Mohan H, et al. Comparative analysis of various cytohistological techniques in diagnosis of lung diseases. Diagn Cytopathol, 2007, 35:26-31.
  • 7Franklin J, Pluetschow A, Paus M, et al. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Am Oncol, 2006, 17 : 1749-1760.
  • 8Bria E, Visca P, Novelli F, et al. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small- cell lung cancer. Eur J Surg Oncol, 2008, 34:593-598.
  • 9Katsimpoula S, Patrinou-Georgoula M, Makrilia N, et al. Overexpression hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer. Anticancer Res, 2009, 29 : 1373- 1382.
  • 10Fielding P,Turnbull L,Prime W,et al.Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection[].Clinical Cancer Research.1999

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部